Results 311 to 320 of about 218,284 (346)

VAD-Nachsorge

2013
U. Boeken, A. Assmann, F. Born, C. Schmid   +3 more
openaire   +1 more source

Vad

1993
openaire   +1 more source

A statistical model-based voice activity detection

IEEE Signal Processing Letters, 1999
Jongseo Sohn, N. Kim, Wonyong Sung
semanticscholar   +1 more source

Phase III study of PSC-833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95)

Cancer, 2006
Montserrat Rue, Richard A Larson, Pieter Sonneveld   +2 more
exaly  

Postoperative Management of the VAD Patient

2022
Sarah Schettle
exaly  

Vascular dementia

Neurology, 1993
G. Roman, T. K. Tatemichi, T. Erkinjuntti, J. L. Cummings, J. Masdeu, J. García, L. Amaducci, J.-M. Orgogozo, A. Brun, A. Hofman, D. M. Moody, M. O'Brien, T. Yamaguchi, J. Grafman, B. P. Drayer, D. Bennett, M. Fisher, J. Ogata, E. Kokmen, F. Bermejo, P. Wolf, P. B. Gorelick, K. L. Bick, A. K. Pajeau, M. A. Bell, C. DeCarli, A. Culebras, A. Korczyn, J. Bogousslavsky, A. Hartmann, P. Scheinberg   +30 more
semanticscholar   +1 more source

Running with a VAD

The Journal of Heart and Lung Transplantation, 2014
L.M. Fuller, J.M. Van Weel, R. Stornebrink, A.T. Burge, K. Hayes, A. Fuller, P. Bergin   +6 more
openaire   +1 more source

Microlens formation on VAD single-mode fibre ends

Electronics Letters, 1982
M Kawachi, T Edahiro, H Toba
exaly  

VAD‐based regimens as primary treatment for multiple myeloma

American journal of hematology/oncology, 1990
R. Alexanian, B. Barlogie, S. Tucker
semanticscholar   +1 more source

Maintenance therapy with alpha‐interferon following first‐line VAD in multiple myeloma

European Journal of Haematology, 1997
A Kars, Ismail Çelik, Emin Kansu
exaly